Overexpression of the PDZ1 Domain of PSD‐95 Diminishes Ischemic Brain Injury Via Inhibition of the GluR6·PSD‐95·MLK3 Pathway

Shu-Qun Hu,Jie Zhu,Dong-Sheng Pei,Yan-Yan Zong,Jing-Zhi Yan,Xiao-Yu Hou,Guang-Yi Zhang
DOI: https://doi.org/10.1002/jnr.22163
IF: 4.433
2009-01-01
Journal of Neuroscience Research
Abstract:Recent studies have shown that kainate (KA) receptors are involved in neuronal cell death induced by seizure, which is mediated by the GluR6·PSD‐95·MLK3 signaling module and subsequent JNK activation. In our previous studies, we demonstrated the neuroprotective role of a GluR6 c‐terminus containing peptide against KA or cerebral ischemia‐induced excitotoxicity in vitro and in vivo. Here, we first report that overexpression of the PDZ1 domain of PSD‐95 protein exerts a protective role against neuronal death induced by cerebral ischemia‐reperfusion in vivo and can prevent neuronal cell death induced by oxygen‐glucose deprivation. Further studies show that overexpression of PDZ1 can perturb the interaction of GluR6 with PSD‐95 and suppress the assembly of the GluR6·PSD‐95·MLK3 signaling module and therefore inhibit JNK activation. Thus, it not only inhibits phosphorylation of c‐Jun and down‐regulates Fas ligand expression but also inhibits phosphorylation of 14‐3‐3 and decreases Bax translocation to mitochondria, decreases the release of cytochrome c, and decreases caspase‐3 activation. Overall, the essential role of the PDZ1 domain of PSD‐95 in apoptotic cell death in neurons provides an experimental foundation for gene therapy of neurodegenerative diseases with overexpression of the PDZ1 domain. © 2009 Wiley‐Liss, Inc.
What problem does this paper attempt to address?